Virtual Issues

List of BJUI Virtual Issues

Virtual Issue: The Continued Role of Radical Prostatectomy


Radical prostatectomy continues to be an important tool in the treatment of prostate cancer. In this Virtual Issue, we present a collection of articles on radical prostatectomy from BJU International and BJUI Compass.

Review of the use of prophylactic drain tubes post‐robotic radical prostatectomy: Dogma or decent practice?
Tatenda C. Nzenza et al.
Retzius-sparing robot-assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single-blind trial with a 1-year follow-up
Xuefeng Qiu et al.
Frailty is a predictor of moderate to severe pain after robot‐assisted laparoscopic prostatectomy: A case‐control study (FRAP study)
Masaki Momota et al.
Randomized Comparison of Techniques for Control of the Dorsal Venous Complex During Robotic-assisted Laparoscopic Radical Prostatectomy
Tom Feng et al.
Virtual reality tumor navigated robotic radical prostatectomy by using three‐dimensional reconstructed multiparametric prostate MRI and 68Ga‐PSMA PET/CT images: A useful tool to guide the robotic surgery? 
Abdullah Erdem Canda et al.
68Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer
David Pfister et al.
Single‐fraction image‐guided robotic radiosurgery efficiently controls local prostate cancer recurrence after radical prostatectomy
A. Spek et al.
Transvesical Robot Assisted Radical Prostatectomy: Initial Experience and Surgical Outcomes
Xiaochen Zhou et al.
Robotic prostatectomy after abandoned open radical prostatectomy—Technical aspects and outcomes
E. O’Connor et al.


Virtual Issue: Artificial Intelligence: More than a trendy topic, truly advancing the understanding of urologic diseases


Introduction by Andrew J. Hung, Assistant Professor of Clinical Urology

Global Prize winner

Computer‐aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm
Junichiro Ishioka et al

Coffey-Krane Prize winner

Use of machine learning to predict early biochemical recurrence after robot‐assisted prostatectomy
Nathan C. Wong et al

A deep‐learning model using automated performance metrics and clinical features to predict urinary continence recovery after robot‐assisted radical prostatectomy
Andrew J. Hung et al

A machine learning‐assisted decision‐support model to better identify patients with prostate cancer requiring an extended pelvic lymph node dissection
Ying Hou et al

Automated differentiation of benign renal oncocytoma and chromophobe renal cell carcinoma on computed tomography using deep learning
Amir Baghdadi et al

Deep learning computer vision algorithm for detecting kidney stone composition
Kristian M. Black et al

Current status of artificial intelligence applications in urology and their potential to influence clinical practice
Jian Chen et al

A better way to predict lymph node involvement using machine‐learning?
Andrew J. Hung

Can machine‐learning algorithms replace conventional statistics?
Andrew J. Hung

Artificial intelligence, three‐dimensional printing and global health
Prokar Dasgupta

Building artificial intelligence‐based personalized predictive models
Mahendra Bhandari and Madhu Reddiboina

The Internet of Skills: use of fifth‐generation telecommunications, haptics and artificial intelligence in robotic surgery
Sandra S.Y. Kim et al

New robots – cost, connectivity and artificial intelligence
Prokar Dasgupta


Virtual Issue: Evaluation and management of urolithiasis: Advancing technology and changing concepts

Introduction by Kemal Sarica and GuoHua Zeng, Co-Presidents, International Alliance of Urolithiasis

The origins of urinary stone disease: upstream mineral formations initiate downstream Randall's plaque
Ryan S. His, Krishna Ramaswamy, Sunita P. Ho, Marshall L. Stoller

Prevalence of kidney stones in China: an ultrasonography based cross-sectional study
Guohua Zeng, Zanlin Mai, Shujie Xia, Zhiping Wang, Keqin Zhang, Li Wang, Yongfu Long, Jinxiang Ma, Yi Li Show P. Wan, Wenqi Wu, Yongda Liu, Zelin Cui, Zhijian Zhao, Jing Qin, Tao Zeng, Yang Liu, Xiaolu Duan, Xin Mai, Zhou Yang, Zhenzhen Kong, Tao Zhang, Chao Cai, Yi Shao, Zhongjin Yue, Shujing Li, Jiandong Ding, Shan Tang, Zhangqun Ye

Accuracy of ultrasonography for renal stone detection and size determination: is it good enough for management decisions?
Vishnu Ganesan, Shubha De, Daniel Greene, Fabio Cesar Miranda Torricelli, Manoj Monga

The natural history of asymptomatic calyceal stones<
Maitrey P. Darrad, Sachin Yallappa, John Metcalfe, Kesavapillai Subramonian

A randomised controlled trial evaluating renal protective effects of selenium with vitamins A, C, E, verapamil, and losartan against extracorporeal shockwave lithotripsy-induced renal injury
Ahmed R. El‐Nahas, Mohamed M. Elsaadany, Diaa‐Eldin Taha, Ahmed M. Elshal, Mohamed Abo El‐Ghar, Amani M. Ismail, Essam A. Elsawy, Hazem H. Saleh, Ehab W. Wafa, Amira Awadalla, Tamer S. Barakat, Khaled Z. Sheir

Surgical outcomes of percutaneous nephrolithotomy in 3402 patients and results of stone analysis in 1559 patients
Syed Adibul Hasan Rizvi, Manzoor Hussain, Syed Hassan Askari, Altaf Hashmi, Murli Lal, Mirza Naqi Zafar

A prospective and randomised trial comparing fluoroscopic, total ultrasonographic, and combined guidance for renal access in mini-percutaneous nephrolithotomy
Wei Zhu, Jiasheng Li, Jian Yuan, Yongda Liu, Shaw P. Wan, Guanzhao Liu, Wenzhong Chen, Wenqi Wu, Jintai Luo, Dongliang Zhong, Defeng Qi, Ming Lei, Wen Zhong, Ze Zhang, Zhaohui He, Zhijian Zhao, Suilin Lu, Yuji Wu, Guohua Zeng

European Section of Urotechnology educational video on fluoroscopic-guided puncture in percutaneous nephrolithotomy: all techniques step by step
Iason Kyriazis, Evangelos Liatsikos, Odysseas Sopilidis, Panagiotis Kallidonis, Andreas Skolarikos, on behalf of the European Section of Urotechnology (ESUT)

Super-mini percutaneous nephrolithotomy (SMP) vs retrograde intrarenal surgery for the treatment of 1-2 cm lower-pole renal calculi: an international multicentre randomised controlled trial
Guohua Zeng, Tao Zhang, Madhu Agrawal, Xiang He, Wei Zhang, Kefeng Xiao, Hulin Li, Xuedong Li, Changbao Xu, Sixing Yang, Jean J. de la Rosette, Junhong Fan, Wei Zhu, Kemal Sarica

α-blockers as medical expulsive therapy for ureteric stones: a Cochrane systematic review
Thijs Campschroer, Xiaoye Zhu, Robin W.M. Vernooij, Tycho M.T.W. Lock


Virtual Issue: Quality of Life and Patient Reported Outcomes

Health‐related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population
Gary W. Chien, Jeff M. Slezak, Teresa N. Harrison, Howard Jung, Joy S. Gelfond, Chengyi Zheng, Edward Wu, Richard Contreras, Ronald K. Loo and Steven J. Jacobsen

Impact of bladder cancer on health‐related quality of life

Angela B. Smith, Byron Jaeger, Laura C. Pinheiro, Lloyd J. Edwards, Hung‐Jui Tan,  Matthew E. Nielsen and Bryce B. Reeve

Long‐term sexual health outcomes in men with classic bladder exstrophy

Timothy S. Baumgartner, Kathy M. Lue, Pokket Sirisreetreerux, Sarita Metzger, Ross G. Everett, Sunil S. Reddy, Ezekiel Young, Uzoma A. Anele, Cameron E. Alexander, Nilay M. Gandhi, Heather N. Di Carlo and John P. Gearhart

Evaluating patient‐reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus‐based Standards for the selection of health Measurement INstruments (COSMIN) checklist

Samantha J. Mason, James W.F. Catto, Amy Downing, Sarah E. Bottomley, Adam W. Glaser and Penny Wright

Health‐related quality of life in active surveillance and radical prostatectomy for low‐risk prostate cancer: a prospective observational study (HAROW ‐ Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting)

Lena Ansmann, Nicola Winter, Nicole Ernstmann, Axel Heidenreich, Lothar Weissbach and Jan Herden

ProCare Trial: a phase II randomized controlled trial of shared care for follow‐up of men with prostate cancer

Jon D. Emery, Michael Jefford, Madeleine King, Dickon Hayne, Andrew Martin, Juanita Doorey, Amelia Hyatt, Emily Habgood, Tee Lim, Cynthia Hawks, Marie Pirotta, Lyndal Trevena and Penelope Schofield 

Quality‐of‐life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone‐releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer

Duncan C. Gilbert, Trinh Duong, Howard G. Kynaston, Abdulla A. Alhasso, Fay H. Cafferty, Stuart D. Rosen, Subramanian Kanaga‐Sundaram, Sanjay Dixit, Marc Laniado,  Sanjeev Madaan, Gerald Collins, Alvan Pope, Andrew Welland, Matthew Nankivell, Richard Wassersug, Mahesh K. B. Parmar, Ruth E. Langley and Paul D. Abel 

Quality Improvement in Cystectomy Care with Enhanced Recovery (QUICCER) study

Janet E. Baack Kukreja, Maureen Kiernan, Bethany Schempp, Aisha Siebert, Adriana Hontar, Benjamin Nelson, James Dolan, Katia Noyes, Ann Dozier, Ahmed Ghazi, Hani H. Rashid, Guan Wu and Edward M. Messing

Patient‐reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments

Evangelia Protopapa, Jan van der Meulen, Caroline M. Moore and Sarah C. Smith

Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort

Pierre Blanchard, John W. Davis, Steven J. Frank, Jeri Kim, Curtis A. Pettaway, Thomas J. Pugh, Louis L. Pisters, John F. Ward, Seungtaek Choi, Brian F. Chapin, Karen Hoffman, Neema Navai, Mary Achim, Sean E. McGuire, Surena F. Matin, Quynh Nguyen, Usama Mahmood, William J. Graber, Hsiang‐Chun Chen, Xuemei Wang and Deborah A. Kuban

Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy

Robert A. Huddart, Alison Birtle, Lauren Maynard, Mark Beresford, Jane Blazeby, Jenny Donovan, John D. Kelly, Tony Kirkbank, Duncan B. McLaren, Graham Mead, Clare Moynihan, Raj Persad, Christopher Scrase, Rebecca Lewis and Emma Hall

Patient–physician communication and health‐related quality of life of patients with localised prostate cancer undergoing radical prostatectomy – a longitudinal multilevel analysis

Nicole Ernstmann, Lothar Weissbach, Jan Herden, Nicola Winter and Lena Ansmann


Virtual Issue: Prostate Artery Embolisation

Editorial - Prostate artery embolisation

Tarun Sabharwal and Rick Popert

Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)

Alistair F. Ray, John Powell, Mark J. Speakman, Nicholas T. Longford, Ranan DasGupta, Timothy Bryant, Sachin Modi, Jonathan Dyer, Mark Harris, Grace Carolan‐Rees and Nigel Hacking

NICE Guidance – Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia

Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia

Nicholas Brown, Duncan Walker, Rhiannon McBean, Morgan Pokorny, Boon Kua, Troy Gianduzzo, Nigel Dunglison, Rachel Esler and John Yaxley

Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open‐label, non‐inferiority trial

Dominik Abt, Gautier Müllhaupt, Livio Mordasini, Sabine Güsewell, Stefan Markart, Valentin Zumstein, Thomas M. Kessler,  Hans‐Peter Schmid, Daniel S. Engeler and Lukas Hechelhammer

Editorial - Prostatic artery embolization: adding to the arsenal against the hapless prostate

Peter Chin

In‐hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trial

Gautier Müllhaupt, Lukas Hechelhammer, Daniel S. Engeler, Sabine Güsewell, Patrick Betschart, Valentin Zumstein, Thomas M. Kessler, Hans‐Peter Schmid, Livio Mordasini and Dominik Abt


Virtual Issue: Best of Asia

Prevalence of urolithiasis among the Uyghur children of China: a population‐based cross‐sectional study

Zanlin Mai, Yongda Liu, Wenqi Wu, Ainiwaer Aierken, Chonghe Jiang, Jesur Batur, Sulitan Wusiman, Jinxiang Ma, Yusi Li, Hai Xu, Aikebaier Ainiwa, Saiding Saimaiti, Aierken Tuerxun and Guohua Zeng

Prevalence of kidney stones in China: an ultrasonography based cross‐sectional study

Guohua Zeng, Zanlin Mai, Shujie Xia, Zhiping Wang, Keqin Zhang, Li Wang, Yongfu Long, Jinxiang Ma, Yi Li, Show P. Wan,  Wenqi Wu, Yongda Liu, Zelin Cui, Zhijian Zhao, Jing Qin, Tao Zeng, Yang Liu, Xiaolu Duan, Xin Mai, Zhou Yang, Zhenzhen Kong, Tao Zhang, Chao Cai, Yi Shao, Zhongjin Yue, Shujing Li, Jiandong Ding, Shan Tang and Zhangqun Ye

Analysis of factors affecting radiation exposure during percutaneous nephrolithotomy procedures

Sudharsan S. Balaji, Mohankumar Vijayakumar, Abhishek G. Singh, Arvind P. Ganpule, Ravindra B. Sabnis and Mahesh R. Desai

Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology

Wai‐Kit Ma, Darren Ming‐Chun Poon, Chi‐Kwok Chan, Tim‐Wai Chan, Foon‐Yiu Cheung, Lap‐Yin Ho, Eric Ka‐Chai Lee, Angus Kwong‐Chuen Leung, Simon Yiu‐Lam Leung, Hing‐Shing So, Po‐Chor Tam and Philip Wai‐Kay Kwong

Retzius‐sparing robot‐assisted radical prostatectomy using the Revo‐i robotic surgical system: surgical technique and results of the first human trial

Ki Don Chang, Ali Abdel Raheem, Young Deuk Choi, Byung Ha Chung and Koon Ho Rha

The role of prostaglandin and E series prostaglandin receptor type 4 receptors in the development of bladder overactivity in a rat model of chemically induced prostatic inflammation

Shinsuke Mizoguchi, Amanda S. Wolf‐Johnson, Jianshu Ni, Kenichi Mori, Takahisa Suzuki, Eiichiro Takaoka, Hiromitsu Mimata,  Donald B. DeFranco, Zhou Wang, Lori A. Birder and Naoki Yoshimura

Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients

Satoshi Washino, Tomohisa Okochi, Kimitoshi Saito, Tsuzumi Konishi, Masaru Hirai, Yutaka Kobayashi and Tomoaki Miyagawa


Virtual Issue: Top Trials in the BJUI

Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial

Shankar Siva, Daniel Pham, Tomas Kron, Mathias Bressel, Jacqueline Lam, Teng Han Tan, Brent Chesson, Mark Shaw, Sarat Chander, Suki Gill, Nicholas R. Brook, Nathan Lawrentschuk, Declan G. Murphy and Farshad Foroudi

Prospective evaluation of 68Gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer

Pim J. van Leeuwen, Louise Emmett, Bao Ho, Warick Delprado, Francis Ting, Quoc Nguyenand Phillip D. Stricker

A prospective randomised placebo‐controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

Claus G. Roehrborn, Michael J. Manyak ,Juan Manuel Palacios‐Moreno, Timothy H. Wilson, Erik P.M. Roos, Javier Cambronero Santos, Dimitrios Karanastasis, Janet Plastino and François Giuliano Raymond C. Rosen

A prospective and randomised trial comparing fluoroscopic, total ultrasonographic, and combined guidance for renal access in mini‐percutaneous nephrolithotomy

Wei Zhu, Jiasheng Li, Jian Yuan, Yongda Liu, Shaw P. Wan, Guanzhao Liu, Wenzhong Chen, Wenqi Wu, Jintai Luo, Dongliang Zhong, Defeng Qi, Ming Lei, Wen Zhong, Ze Zhang, Zhaohui He, Zhijian Zhao, Suilin Lu, Yuji Wu and Guohua Zeng

Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients

Angelika Borkowetz, Boris Hadaschik, Ivan Platzek, Marieta Toma, Georgi Torsev, Theresa Renner, Roman Herout, Martin Baunacke, Michael Laniado, Gustavo Baretton, Jan Philipp Radtke, Claudia Kesch, Markus Hohenfellner, Michael Froehner, Heinz‐Peter Schlemmer, Manfred Wirth and Stefan Zastrow

36‐month data for the AdVance XP® male sling: results of a prospective multicentre study

Ricarda M. Bauer, Markus T. Grabbert, Benedikt Klehr, Peter Gebhartl, Christian Gozzi, Roland Homberg, Florian May, Peter Rehder, Christian G. Stief and Alexander Kretschmer

Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy

Robert A. Huddart, Alison Birtle, Lauren Maynard, Mark Beresford, Jane Blazeby, Jenny Donovan, John D. Kelly, Tony Kirkbank, Duncan B. McLaren, Graham Mead, Clare Moynihan, Raj Persad, Christopher Scrase, Rebecca Lewis and Emma Hall

Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity‐matched comparison with transurethral resection of the prostate (the UK‐ROPE study)

Alistair F. Ray, John Powell, Mark J. Speakman, Nicholas T. Longford, Ranan DasGupta, Timothy Bryant, Sachin Modi, Jonathan Dyer, Mark Harris, Grace Carolan‐Rees and Nigel Hacking

Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non‐muscle‐invasive bladder cancer

Takehisa Onishi, Yusuke Sugino, Takuji Shibahara, Satoru Masui, Tadashi Yabana and Takeshi Sasaki

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

Sender Herschorn, Christopher R. Chapple, Paul Abrams, Salvador Arlandis, David Mitcheson, Kyu‐Sung Lee, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Rob van Maanen and Dudley Robinson

Prostatic urethral lift vs transurethral resection of the prostate: 2‐year results of the BPH6 prospective, multicentre, randomized study

Christian Gratzke, Neil Barber, Mark J. Speakman, Richard Berges, Ulrich Wetterauer, Damien Greene, Karl‐Dietrich Sievert, Christopher R. Chapple, Jacob M. Patterson, Lasse Fahrenkrug, Martin Schoenthaler and Jens Sonksen

First‐line therapy with dacomitinib, an orally available pan‐HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open‐label, single‐arm, single‐centre, phase 2 study

Andrea Necchi, Salvatore Lo Vullo, Federica Perrone, Daniele Raggi, Patrizia Giannatempo, Giuseppina Calareso, Nicola Nicolai, Luigi Piva, Davide Biasoni, Mario Catanzaro, Tullio Torelli, Silvia Stagni, Elena Togliardi, Maurizio Colecchia, Adele Busico, Annunziata Gloghini, Adele Testi, Luigi Mariani and Roberto Salvioni

ProCare Trial: a phase II randomized controlled trial of shared care for follow‐up of men with prostate cancer

Jon D. Emery, Michael Jefford, Madeleine King, Dickon Hayne, Andrew Martin, Juanita Doorey, Amelia Hyatt, Emily Habgood, Tee Lim, Cynthia Hawks, Marie Pirotta, Lyndal Trevena and Penelope Schofield

Quality‐of‐life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone‐releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer

Duncan C. Gilbert, Trinh Duong, Howard G. Kynaston, Abdulla A. Alhasso, Fay H. Cafferty, Stuart D. Rosen, Subramanian Kanaga‐Sundaram, Sanjay Dixit, Marc Laniado, Sanjeev Madaan, Gerald Collins, Alvan Pope, Andrew Welland, Matthew Nankivell, Richard Wassersug, Mahesh K. B. Parmar, Ruth E. Langley and Paul D. Abel


Virtual Issue: Best of the UK 2019

 

Contemporary surgical management of renal oncocytoma: a nation's outcome

Joana B. Neves, John Withington, Sarah Fowler, Prasad Patki, Ravi Barod, Faiz Mumtaz, Tim O'Brien, Michael Aitchison, Axel Bex and Maxine G. B. Tran on behalf of The British Association of Urological Surgeons (BAUS)

Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol

Amr Abdel Raheem, Marco Capece, Odunayo Kalejaiye, Tarek Abdel‐Raheem, Marco Falcone, Mark Johnson, Oliver G. Ralph, Giulio Garaffa, Andrew N. Christopher and David J. Ralph

Progression and treatment rates using an active surveillance protocol incorporating image‐guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable‐risk prostate cancer

David Thurtle, Tristan Barrett, Vineetha Thankappan‐Nair, Brendan Koo, Anne Warren, Christof Kastner, Kasra Saeb‐Parsy, Jenna Kimberley‐Duffell and Vincent J. Gnanapragasam

Male circumcision for the prevention of human immunodeficiency virus (HIV) acquisition: a meta‐analysis

Sanjeev C. Sharma, Nicholas Raison, Shamim Khan, Majid Shabbir, Prokar Dasgupta and Kamran Ahmed

Intracorporeal robot-assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains

Wei Shen Tan, Mae‐Yen Tan, Benjamin W. Lamb, Ashwin Sridhar, Anna Mohammed, Hilary Baker, Senthil Nathan, Timothy Briggs, Melanie Tan and John D. Kelly

First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune (R)

Bob Yang and Stephen Foley

Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation

Mehran Afshar, Henry Goodfellow, Francesca Jackson‐Spence, Felicity Evison, John Parkin, Richard T. Bryan, Helen Parsons, Nicholas D. James and Prashant Patel

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis

Marcus J. Drake, Victor W. Nitti, David A. Ginsberg, Benjamin M. Brucker, Zsolt Hepp, Rachael McCool, Julie M. Glanville, Kelly Fleetwood, Daniel James and Christopher R. Chapple

The British Association of Urological Surgeons (BAUS) radical prostatectomy audit 2014/2015-an update on current practice and outcomes by centre and surgeon case-volume

Sinan Khadhouri, Catherine Miller, Sarah Fowler, Luke Hounsome, Alan McNeill, Jim Adshead and John S. McGrath on behalf of the BAUS Section of Oncology

Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity‐matched comparison with transurethral resection of the prostate (the UK‐ROPE study)

Alistair F. Ray, John Powell, Mark J. Speakman, Nicholas T. Longford, Ranan DasGupta, Timothy Bryant, Sachin Modi, Jonathan Dyer, Mark Harris, Grace Carolan‐Rees and Nigel Hacking

National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting

Mrishta Brizmohun Appayya, Jim Adshead, Hashim U. Ahmed, Clare Allen, Alan Bainbridge, Tristan Barrett, Francesco Giganti, John Graham, Phil Haslam, Edward W. Johnston, Christof Kastner, Alexander P.S. Kirkham, Alexandra Lipton, Alan McNeill, Larissa Moniz, Caroline M. Moore, Ghulam Nabi, Anwar R. Padhani, Chris Parker, Amit Patel, Jacqueline Pursey, Jonathan Richenberg, John Staffurth, Jan van der Meulen, Darren Walls and Shonit Punwani

Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy

Sukhchain S. Bansal, Tara Dogra, Peter W. Smith, Maisarah Amran, Ishna Auluck, Maninder Bhambra, Manraj S. Sura, Edward Rowe and Anthony Koupparis

Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naive men with suspicion of prostate cancer

Nienke L. Hansen, Tristan Barrett, Claudia Kesch, Lana Pepdjonovic, David Bonekamp, Richard O'Sullivan, Florian Distler, Anne Warren, Christina Samel, Boris Hadaschik, Jeremy Grummet and Christof Kastner

Urinary, bowel and sexual health in older men from Northern Ireland

David W. Donnelly, Conan Donnelly, Therese Kearney, David Weller, Linda Sharp, Amy Downing, Sarah Wilding, Penny Wright,  Paul Kind, James W.F. Catto and William R. Cross 

Real-world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer

Robert J. Rulach, Stephen McKay, Sam Neilson, Lillian White, Jan Wallace, Ross Carruthers, Carolynn Lamb, Almudena Cascales, Husam Marashi, Hilary Glen, Balaji Venugopal, Azmat Sadoyze, Norma Sidek, J. Martin Russell, Abdulla Alhasso,  David Dodds, Jennifer Laskey, Robert J. Jones and Nicholas MacLeod


Virtual Issue: Best of 2017/8

 

In this free Virtual Issue, BJUI Editor Prof Prokar Dasgupta has selected some of the most important papers published in the BJUI over the last two years, including a mix of trials and reviews from around the world.

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer

Pim J. van Leeuwen, Louise Emmett, Bao Ho, Warick Delprado, Francis Ting, Quoc Nguyen and Phillip D. Stricker

Initial multicentre experience of 68gallium‐PSMA PET/CT guided robot‐assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited

Amila Siriwardana, James Thompson, Pim J. van Leeuwen, Shaela Doig, Anton Kalsbeek, Louise Emmett, Warick Delprado, David Wong, Hemamali Samaratunga, Anne‐Maree Haynes, Geoff Coughlin and Phillip Stricker

Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy

Robert A. Huddart, Alison Birtle, Lauren Maynard, Mark Beresford, Jane Blazeby, Jenny Donovan, John D. Kelly, Tony Kirkbank, Duncan B. McLaren, Graham Mead, Clare Moynihan, Raj Persad, Christopher Scrase, Rebecca Lewis and Emma Hall

Prevalence of kidney stones in China: an ultrasonography based cross‐sectional study

Guohua Zeng, Zanlin Mai, Shujie Xia, Zhiping Wang, Keqin Zhang, Li Wang, Yongfu Long, Jinxiang Ma, Yi Li, Show P. Wan, Wenqi Wu, Yongda Liu, Zelin Cui, Zhijian Zhao, Jing Qin, Tao Zeng, Yang Liu, Xiaolu Duan, Xin Mai, Zhou Yang, Zhenzhen Kong, Tao Zhang, Chao Cai, Yi Shao, Zhongjin Yue, Shujing Li, Jiandong Ding, Shan Tang and Zhangqun Ye

Future of robotic surgery in urology

Jens J. Rassweiler, Riccardo Autorino, Jan Klein, Alex Mottrie, Ali Serdar Goezen, Jens‐Uwe Stolzenburg, Koon H. Rha, Marc Schurr, Jihad Kaouk, Vipul Patel, Prokar Dasgupta and Evangelos Liatsikos

Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous negative biopsy

Nienke L. Hansen, Claudia Kesch, Tristan Barrett, Brendan Koo, Jan P. Radtke, David Bonekamp, Heinz‐Peter Schlemmer, Anne Y. Warren, Kathrin Wieczorek, Markus Hohenfellner, Christof Kastner and Boris Hadaschik

Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity‐matched comparison with transurethral resection of the prostate (the UK‐ROPE study)

Alistair F. Ray, John Powell, Mark J. Speakman, Nicholas T. Longford, Ranan DasGupta, Timothy Bryant, Sachin Modi, Jonathan Dyer, Mark Harris, Grace Carolan‐Rees and Nigel Hacking

Progression and treatment rates using an active surveillance protocol incorporating image‐guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable‐risk prostate cancer

David Thurtle, Tristan Barrett, Vineetha Thankappan‐Nair, Brendan Koo, Anne Warren, Christof Kastner, Kasra Saeb‐Parsy, Jenna Kimberley‐Duffell and Vincent J. Gnanapragasam

A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol

Michael S. Hofman, Declan G. Murphy, Scott G. Williams, Tatenda Nzenza, Alan Herschtal, Richard De Abreu Lourenco, Dale, L. Bailey, Ray Budd, Rodney J. Hicks, Roslyn J. Francis and Nathan Lawrentschuk

The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date

Sophie M. Bruinsma, Liying Zhang, Monique J. Roobol, Chris H. Bangma, Ewout W. Steyerberg, Daan Nieboer, Mieke Van Hemelrijck and Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium

Laparoscopic and robot‐assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review

Dragan Ilic, Sue M. Evans, Christie Ann Allan, Jae Hung Jung, Declan Murphy and Mark Frydenberg

Does robot‐assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases?

Won Sik Jang, Myung Soo Kim, Won Sik Jeong, Ki Don Chang, Kang Su Cho, Won Sik Ham, Koon Ho Rha, Sung Joon Hong and Young Deuk Choi


Virtual Issue: Best of the US 2019

Small American flag

 

We hope you will enjoy the BJUI Editor-in-Chief’s selection of the best of recent papers from the USA published as a BJUI Virtual Issue to coincide with AUA 2019.

The United States opioid epidemic: a review of the surgeon's contribution to it and health policy initiatives
Katherine Theisen, Bruce Jacobs, Liam Macleod and Benjamin Davies

‘Trifecta’ outcomes of robot‐assisted partial nephrectomy in solitary kidney: a Vattikuti Collective Quality Initiative (VCQI) database analysis
Sohrab Arora, Ronney Abaza, James M. Adshead, Rajesh K. Ahlawat, Benjamin J. Challacombe, Prokar Dasgupta, Giorgio Gandaglia, Daniel A. Moon, Thyavihally B. Yuvaraja, Umberto Capitanio, Alessandro Larcher, Francesco Porpiglia, James R. Porter, Alexander Mottrie, Mahendra Bhandari and Craig Rogers

A prospective randomised placebo‐controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)
Claus G. Roehrborn, Michael J. Manyak, Juan Manuel Palacios‐Moreno, Timothy H. Wilson, Erik P.M. Roos, Javier Cambronero, Santos Dimitrios Karanastasis, Janet Plastino, François Giuliano and Raymond C. Rosen

Development and internal validation of a side‐specific, multiparametric magnetic resonance imaging‐based nomogram for the prediction of extracapsular extension of prostate cancer
Alberto Martini, Akriti Gupta, Sara C. Lewis, Shivaram Cumarasamy, Kenneth G. Haines III, Alberto Briganti, Francesco Montorsi and Ashutosh K. Tewari

The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta‐analysis
Bimal Bhindi, Christopher J. D. Wallis, Stephen A. Boorjian, R. Houston Thompson, Ann Farrell, Simon P. Kim, Jose A. Karam, Umberto Capitanio, Dragan Golijanin, Bradley C. Leibovich and Boris Gershman

Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle‐invasive bladder cancer
Chad R. Ritch, Raymond Balise, Nachiketh Soodana Prakash, David Alonzo, Katherine Almengo, Mahmoud Alameddine, Vivek Venkatramani, Sanoj Punnen, Dipen J. Parekh and Mark L. Gonzalgo

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
Sasha C. Druskin, Jeffrey J. Tosoian, Allen Young, Sarah Collica, Arnav Srivastava, Kamyar Ghabili, Katarzyna J. Macura, H. Ballentine Carter, Alan W. Partin, Lori J. Sokoll, Ashley E. Ross and Christian P. Pavlovich

Multiple growth periods predict unfavourable pathology in patients with small renal masses
Alex Jang, Hiten D. Patel, Mark Riffon, Michael A. Gorin, Alice Semerjian, Michael H. Johnson, Mohamad E. Allaf and Phillip M. Pierorazio

Guideline of guidelines: asymptomatic microscopic haematuria
Brian J. Linder, Edward J. Bass, Hugh Mostafid and Stephen A. Boorjian

Surgical management of penile carcinoma in situ: results from an international collaborative study and review of the literature
Juan Chipollini, Sylvia Yan, Sarah R. Ottenhof, Yao Zhu, Désirée Draeger, Adam S. Baumgarten, Dominic H. Tang, Chris Protzel, Ding‐wei Ye, Oliver W. Hakenberg, Simon Horenblas, Nicholas A. Watkin and Philippe E. Spiess

Impact of testosterone replacement therapy on thromboembolism, heart disease and obstructive sleep apnoea in men
Alexander P. Cole, Julian Hanske, Wei Jiang, Nicollette K. Kwon, Stuart R. Lipsitz, Martin Kathrins, Peter A. Learn, Maxine Sun, Adil H. Haider, Shehzad Basaria and Quoc‐Dien Trinh

Impact of bladder cancer on health‐related quality of life
Angela B. Smith, Byron Jaeger, Laura C. Pinheiro, Lloyd J. Edwards, Hung‐Jui Tan, Matthew E. Nielsen and Bryce B. Reeve


NICE Guidance in BJU International

NICE Guidance Articles

BJU International is proud to publish the National Institute of Health and Care Excellence (NICE) Guidance. Launched in 2017, and free for you to download, below you will find the complete collection of NICE Guidance articles published in BJUI

Editorial:

NICE guidance and the BJUI

NICE Guidance:

NICE Guidance – Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia

DOI:10.1111/bju.14863
First published: 22 August 2019

NICE Guidance – Prostate cancer: diagnosis and management

DOI: 10.1111/bju.14809
First published: 17 June 2019

NICE Guidance – Urinary incontinence and pelvic organ prolapse in women: management

DOI: 10.1111/bju.14763
First published: 22 April 2019

NICE Guideline – Renal and ureteric stones: assessment and management

DOI: 10.1111/bju.14654
First published: 17 January 2019

NICE Guidance – Nivolumab for previously treated advanced renal cell carcinoma

DOI: 10.1111/bju.14482
First published: 06 September 2018

NICE Advice – Prolaris gene expression assay for assessing long‐term risk of prostate cancer progression

DOI: 10.1111/bju.14452
First published: 07 August 2018

Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia

DOI: 10.1111/bju.14404
First published: 11 June 2018

Complicated urinary tract infections: ceftolozane/tazobactam

DOI: 10.1111/bju.14364
First published: 21 May 2018

Sepsis: recognition, diagnosis and early management

DOI: 10.1111/bju.14179
First published: 31 March 2018

Routine preoperative tests for elective surgery

DOI: 10.1111/bju.14079
First published: 09 January 2018

Bladder cancer: diagnosis and management of bladder cancer

DOI: 10.1111/bju.14045
First published: 23 November 2017

Enzalutamide for treating metastatic hormone‐relapsed prostate cancer before chemotherapy is indicated

DOI: 10.1111/bju.13936
First published: 18 July 2017

GreenLight XPS for treating benign prostatic hyperplasia

DOI: 10.1111/bju.13897
First published: 23 May 2017


 

Virtual Issue: Best of Australia & New Zealand 2019

‘Trifecta’ outcomes of robot‐assisted partial nephrectomy in solitary kidney: a Vattikuti Collective Quality Initiative (VCQI) database analysis
Sohrab Arora, Ronney Abaza, James M. Adshead, Rajesh K. Ahlawat, Benjamin J. Challacombe, Prokar Dasgupta, Giorgio Gandaglia, Daniel A. Moon, Thyavihally B. Yuvaraja, Umberto Capitanio, Alessandro Larcher, Francesco Porpiglia, James R. Porter, Alexander Mottrie, Mahendra Bhandari and Craig Rogers

Focal irreversible electroporation as primary treatment for localized prostate cancer
Willemien van den Bos, Matthijs J. Scheltema, Amila R. Siriwardana, Anton M.F. Kalsbeek, James E. Thompson, Francis Ting, Maret Böhm, Anne‐Maree Haynes, Ron Shnier, Warick Delprado and Phillip D. Stricker

Laparoscopic and robot‐assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review
Dragan Ilic, Sue M. Evans, Christie Ann Allan, Jae Hung Jung, Declan Murphy and Mark Frydenberg

Radiotherapy‐related complications presenting to a urology department: a more common problem than previously thought?
Joyce L. Ma, Derek B. Hennessey, Bradley P. Newell, Damien M. Bolton and Nathan Lawrentschuk

Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy‐naïve men with suspicion of prostate cancer
Nienke L. Hansen, Tristan Barrett, Claudia Kesch, Lana Pepdjonovic, David Bonekamp, Richard O'Sullivan, Florian Distler, Anne Warren, Christina Samel, Boris Hadaschik, Jeremy Grummet and Christof Kastner

Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate‐tolerant cells
Laura H. Porter, Kohei Hashimoto, Mitchell G. Lawrence, Carmel Pezaro, David Clouston, Hong Wang, Melissa Papargiris, Heather Thorne, Jason Li, kConFab, Andrew Ryan, Sam Norden, Daniel Moon, Damien M. Bolton, Shomik Sengupta, Mark Frydenberg, Declan G. Murphy, Gail P. Risbridger and Renea A. Taylor

Intracorporeal robot‐assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains
Wei Shen Tan, Mae‐Yen Tan, Benjamin W. Lamb, Ashwin Sridhar, Anna Mohammed, Hilary Baker, Senthil Nathan, Timothy Briggs, Melanie Tan and John D. Kelly

A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol
Michael S. Hofman, Declan G. Murphy, Scott G. Williams, Tatenda Nzenza, Alan Herschtal, Richard De Abreu Lourenco, Dale L. Bailey, Ray Budd, Rodney J. Hicks, Roslyn J. Francis and Nathan Lawrentschuk

Single‐use disposable digital flexible ureteroscopes: an ex vivo assessment and cost analysis
Derek B. Hennessey, Grzegorz L. Fojecki, Nathan P. Papa, Nathan Lawrentschuk and Damien Bolton

Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12‐month randomized controlled trial in men with prostate cancer
Dennis R. Taaffe, Laurien M. Buffart, Robert U. Newton, Nigel Spry, James Denham, David Joseph, David Lamb, Suzanne K. Chambers and Daniel A. Galvão


Virtual Issue: Best of China 2019

To celebrate Chinese New Year, as we move into the Year of the Pig, BJUI presents the best recent papers from China published in the journal.

Prevalence of kidney stones in China: an ultrasonography based cross‐sectional study
Guohua Zeng, Zanlin Mai, Shujie Xia, Zhiping Wang, Keqin Zhang, Li Wang, Yongfu Long, Jinxiang Ma, Yi Li, Show P. Wan, Wenqi Wu, Yongda Liu, Zelin Cui, Zhijian Zhao, Jing Qin, Tao Zeng, Yang Liu, Xiaolu Duan, Xin Mai, Zhou Yang, Zhenzhen Kong, Tao Zhang, Chao Cai, Yi Shao, Zhongjin Yue, Shujing Li, Jiandong Ding, Shan Tang and Zhangqun Ye

Chromogranin A and neurone‐specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration‐resistant prostate cancer
Liancheng Fan, Yanqing Wang, Chenfei Chi, Jiahua Pan, Shangguan Xun, Zhixiang Xin, Jianian Hu, Lixin Zhou, Baijun Dong and Wei Xue

Comparison of lesions detected and undetected by template‐guided transperineal saturation prostate biopsy
Zhipeng Mai, Yu Xiao, Weigang Yan, Yi Zhou, Zhien Zhou, Zhiyong Liang, Zhigang Ji and Hanzhong Li

Actual lowering effect of metabolic syndrome on serum prostate‐specific antigen levels is partly concealed by enlarged prostate: results from a large‐scale population‐based study
Sicong Zhao, Ming Xia, Jianchun Tang and Yong Yan

Super‐mini percutaneous nephrolithotomy (SMP) vs retrograde intrarenal surgery for the treatment of 1–2 cm lower‐pole renal calculi: an international multicentre randomised controlled trial
Guohua Zeng, Tao Zhang, Madhu Agrawal, Xiang He, Wei Zhang, Kefeng Xiao, Hulin Li, Xuedong Li, Changbao Xu, Sixing Yang,  Jean J. de la Rosette, Junhong Fan, Wei Zhu and Kemal Sarica

Transumbilical laparoendoscopic single‐site radical prostatectomy and cystectomy with the aid of a transurethral port: a feasibility study
Jian Su, Qingyi Zhu, Lin Yuan, Yang Zhang, Qingling Zhang and Yunfei Wei

Controlled release of insulin‐like growth factor 1 enhances urethral sphincter function and histological structure in the treatment of female stress urinary incontinence in a rat model
Hao Yan, Liren Zhong, Yaodong Jiang, Jian Yang, Junhong Deng, Shicheng Wei, Emmanuel Opara, Anthony Atala, Xiangming Mao, Margot S. Damaser and Yuanyuan Zhang

Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro‐Oncology
Darren Ming‐Chun Poon, Chi‐Kwok Chan, Tim‐Wai Chan, Foon‐Yiu Cheung, Philip Wai‐Kay Kwong, Eric Ka‐Chai Lee, Angus Kwong‐Chuen Leung, Simon Yiu‐Lam Leung, Wai‐Kit Ma, Hing‐Shing So, Po‐Chor Tam and Lap‐Yin Ho


Virtual Issue: Biopsy of the Prostate - State of the Art

Prostate Biopsy 2018

 

Cost‐effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer
Christine L. Barnett, Matthew S. Davenport, Jeffrey S. Montgomery, John T. Wei, James E. Montie and Brian T. Denton 

Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000–2012
Daniela Danneman, Linda Drevin, Brett Delahunt, Hemamali Samaratunga, David Robinson, Ola Bratt, Stacy Loeb, Pär Stattin and Lars Egevad 

Diagnostic accuracy of a five‐point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image‐fusion targeted biopsy of the prostate
Toshitaka Shin, Thomas B. Smyth, Osamu Ukimura, Nariman Ahmadi, Andre Luis Castro Abreu, Chisato Ohe, Masakatsu Oishi, Hiromitsu Mimata and Inderbir S. Gill 

,

Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients
Satoshi Washino, Tomohisa Okochi, Kimitoshi Saito, Tsuzumi Konishi, Masaru Hirai, Yutaka Kobayashi and Tomoaki Miyagawa 

Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients
Angelika Borkowetz, Boris Hadaschik, Ivan Platzek, Marieta Toma, Georgi Torsev, Theresa Renner, Roman Herout, Martin Baunacke, Michael Laniado, Gustavo Baretton, Jan Philipp Radtke, Claudia Kesch, Markus Hohenfellner, Michael Froehner, Heinz‐Peter Schlemmer, Manfred Wirth and Stefan Zastrow 

Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous negative biopsy
Nienke L. Hansen, Claudia Kesch, Tristan Barrett, Brendan Koo, Jan P. Radtke, David Bonekamp, Heinz‐Peter Schlemmer, Anne Y. Warren, Kathrin Wieczorek, Markus Hohenfellner, Christof Kastner and Boris Hadaschik 

Comparison between target magnetic resonance imaging (MRI) in‐gantry and cognitively directed transperineal or transrectal‐guided prostate biopsies for Prostate Imaging–Reporting and Data System (PI‐RADS) 3–5 MRI lesions
Anna J. Yaxley, John W. Yaxley, Isaac A. Thangasamy, Emma Ballard and Morgan R. Pokorny

Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy‐naïve men with suspicion of prostate cancer
Nienke L. Hansen, Tristan Barrett, Claudia Kesch, Lana Pepdjonovic, David Bonekamp, Richard O'Sullivan, Florian Distler, Anne Warren, Christina Samel, Boris Hadaschik, Jeremy Grummet and Christof Kastner  

The influence of prostate‐specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7–10 prostate cancer in a repeat biopsy setting
Nienke L. Hansen, Tristan Barrett, Brendan Koo, Andrew Doble, Vincent Gnanapragasam, Anne Warre,n Christof Kastner and Ola Bratt 

Risk‐stratification based on magnetic resonance imaging and prostate‐specific antigen density may reduce unnecessary follow‐up biopsy procedures in men on active surveillance for low‐risk prostate cancer
Arnout R. Alberts, Monique J. Roobol, Frank‐Jan H. Drost, Geert J. Leenders, Leonard P. Bokhorst, Chris H. Bangma and Ivo G. Schoots

Value of 3‐Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance
Rodrigo R. Pessoa, Publio C. Viana, Romulo L. Mattedi, Giuliano B. Guglielmetti, Mauricio D. Cordeiro, Rafael F. Coelho, William C. Nahas and Miguel Srougi 

Prognostic utility of biopsy‐derived cell cycle progression score in patients with National Comprehensive Cancer Network low‐risk prostate cancer undergoing radical prostatectomy: implications for treatment guidance
Jeffrey J. Tosoian, Meera R. Chappidi, Jay T. Bishoff, Stephen J. Freedland, Julia Reid, Michael Brawer, Steven Stone, Thorsten Schlomm and Ashley E. Ross 


Virtual Issue: Guideline of Guidelines

GOG VI 2015

 

Guideline of guidelines: bladder pain syndrome

Sachin Malde, Stefano Palmisani, Adnan Al‐Kaisy and Arun Sahai 

Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer
Michelle Lancee, Kari A.O. Tikkinen, Theo M. Reijke, Vesa V. Kataja, Katja K.H. Aben and Robin W.M. Vernooij 

Guideline of guidelines: asymptomatic microscopic haematuria
Brian J. Linder, Edward J. Bass, Hugh Mostafid and Stephen A. Boorjian 

Guideline of guidelines: non‐muscle‐invasive bladder cancer
Solomon L. Woldu, Aditya Bagrodia and Yair Lotan 

Guideline of guidelines: priapism
Asif Muneer and David Ralph 

Guideline of guidelines: thromboprophylaxis for urological surgery
Philippe D. Violette, Rufus Cartwright, Matthias Briel, Kari A.O. Tikkinen and Gordon H. Guyatt 

Guideline of guidelines: follow‐up after nephrectomy for renal cell carcinoma
Timothy J. Williamson, John R. Pearson, Joseph Ischia, Damien M. Bolton and Nathan Lawrentschuk 

Guideline of guidelines: a review of urological trauma guidelines
Darren J. Bryk and Lee C. Zhao 

Guideline of guidelines: urinary incontinence
Raveen Syan and Benjamin M. Brucker 

Guideline of Guidelines: Imaging of Localized Prostate Cancer
Daniel A. Wollin and Danil V. Makarov 

Guideline of guidelines: kidney stones
Justin B. Ziemba and Brian R. Matlaga 

Guideline of guidelines: prostate cancer screening
Stacy Loeb 


 

Best of UK 2018

We hope you will enjoy the BJUI Editor-in-Chief’s selection of the best of recent papers from the UK published as a BJUI Virtual Issue to coincide with BAUS 2018. This year’s articles include a mix of original articles covering a wide range of urological topics.

Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous negative biopsy
Nienke L. Hansen, Claudia Kesch, Tristan Barrett, Brendan Koo, Jan P. Radtke, David Bonekamp, Heinz‐Peter Schlemmer, Anne Y. Warren, Kathrin Wieczorek, Markus Hohenfellner, Christof Kastner and Boris Hadaschik

The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivity
Marcus J. Drake, Anthony Kanai, Dominika A. Bijos, Youko Ikeda, Irina Zabbarova, Bahareh Vahabi and Christopher H. Fry

Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy
Robert A. Huddart, Alison Birtle, Lauren Maynard, Mark Beresford, Jane Blazeby, Jenny Donovan, John D. Kelly, Tony Kirkbank, Duncan B. McLaren, Graham Mead, Clare Moynihan, Raj Persad, Christopher Scrase, Rebecca Lewis and Emma Hall

Quantifying severe urinary complications after radical prostatectomy: the development and validation of a surgical performance indicator using hospital administrative data
Arunan Sujenthiran, Susan C. Charman, Matthew Parry, Julie Nossiter, Ajay Aggarwal, Prokar Dasgupta, Heather Payne, Noel W. Clarke, Paul Cathcart and Jan Meulen

A core outcome set for localised prostate cancer effectiveness trials
Steven MacLennan, Paula R. Williamson, Hanneke Bekema, Marion Campbell, Craig Ramsay, James N'Dow, Sara MacLennan, Luke Vale, Philipp Dahm, Nicolas Mottet, Thomas Lam and the COMPACTERS Study Group

Percutaneous nephrolithotomy access by urologist or interventional radiologist: practice and outcomes in the UK
James N. Armitage, John Withington, Sarah Fowler, William J. G. Finch, Neil A. Burgess, Stuart O. Irving, Jonathan Glass, Oliver J. Wiseman and the BAUS section of Endourology

Quality‐of‐life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone‐releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer
Duncan C. Gilbert, Trinh Duong, Howard G. Kynaston, Abdulla A. Alhasso, Fay H. Cafferty, Stuart D. Rosen, Subramanian Kanaga‐Sundaram, Sanjay Dixit, Marc Laniado, Sanjeev Madaan, Gerald Collins, Alvan Pope, Andrew Welland, Matthew Nankivell, Richard Wassersug, Mahesh K. B. Parmar, Ruth E. Langley and Paul D. Abel

Pre‐biopsy 3‐Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot‐assisted radical prostatectomy
Uday Patel, Prokar Dasgupta, Ben Challacombe, Declan Cahill, Christian Brown, Roshnee Patel and Roger Kirby

Prospective study comparing video‐endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8‐year period
Vivekanandan Kumar and K. Krishna Sethia

Competency based training in robotic surgery: benchmark scores for virtual reality robotic simulation
Nicholas Raison, Kamran Ahmed, Nicola Fossati, Nicolò Buffi, Alexandre Mottrie, Prokar Dasgupta and Henk Van Der Poel

Who is at risk of death from nephrectomy? An analysis of thirty‐day mortality after 21 380 nephrectomies in 3 years of the British Association of Urological Surgeons (BAUS) National Nephrectomy Audit
Archie Fernando, Sarah Fowler, Mieke Van Hemelrijck, Tim O'Brien and the British Association of Urological Surgeons (BAUS)

Contemporary role of ureterolysis in retroperitoneal fibrosis: treatment of last resort or first intent? An analysis of 50 cases
Tim O'Brien and Archie Fernando



Prostate-Specific Membrane Antigen

Prostate‐specific membrane antigen from diagnostic to therapeutic target: radionuclide therapy comes of age in prostate cancer
John A. Violet and Michael S. Hofman

Initial multicentre experience of 68gallium‐PSMA PET/CT guided robot‐assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited
Amila Siriwardana, James Thompson, Pim J. Leeuwen, Shaela Doig, Anton Kalsbeek, Louise Emmett, Warick Delprado,, David Wong, Hemamali Samaratunga, Anne‐Maree Haynes, Geoff Coughlin and Phillip Stricker

The use of 68 Ga‐PSMA PET CT in men with biochemical recurrence after definitive treatment of acinar prostate cancer
Greta Meredith, David Wong, John Yaxley, Geoff Coughlin, Les Thompson, Boon Kua and Troy Gianduzzo

A prospective randomised multi‐centre study of the impact of Ga‐68 PSMA‐PET/CT imaging for staging high risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol
Michael S. Hofman, Declan G. Murphy, Scott G. Williams, Tatenda Nzenza, Alan Herschtal, Richard De Abreu Lourenco, Dale L. Bailey, Ray Budd, Rodney J. Hicks, Roslyn J. Francis and Nathan Lawrentschuk

Clinical impact of 68Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate‐specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach
Simone Albisinni, Carlos Artigas, Fouad Aoun, Ibrahim Biaou, Julien Grosman, Thierry Gil, Eric Hawaux, Ksenija Limani, Francois‐Xavier Otte, Alexandre Peltier, Spyridon Sideris, Nicolas Sirtaine, Patrick Flamen and Roland Velthoven

68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
Pim J. Leeuwen, Phillip Stricker, George Hruby, Andrew Kneebone, Francis Ting, Ben Thompson, Quoc Nguyen, Bao Ho and Louise Emmett

Value of 111In‐prostate‐specific membrane antigen (PSMA)‐radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow‐up
Isabel Rauscher, Charlotte Düwel, Martina Wirtz, Margret Schottelius, Hans‐Jürgen Wester, Kristina Schwamborn, Bernhard Haller, Markus Schwaiger, Jürgen E. Gschwend, Matthias Eiber and Tobias Maurer

Prospective evaluation of 68Gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer
Pim J. Leeuwen, Louise Emmett, Bao Ho, Warick Delprado, Francis Ting, Quoc Nguyen and Phillip D. Stricker



Active Surveillance for Prostate Cancer

As we become better at risk stratifying patients with prostate cancer, many are now being managed by active surveillance rather than active treatment. This is a hot topic with new perspectives that vary in different parts of the world.

In this virtual issue of the BJUI I have the privilege of presenting the best papers on active surveillance, all in one place, for your reading pleasure. Hope you enjoy it. As always, any comments are most welcome.

 

Prokar Dasgupta, Editor-in-Chief

Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable‐risk prostate cancer undergoing active surveillance
John W. Davis, John F. Ward, Curtis A. Pettaway, Xuemei Wang, Deborah Kuban, Steven J. Frank, Andrew K. Lee, Louis L. Pisters, Surena F. Matin, Jay B. Shah, Jose A. Karam, Brian F. Chapin, John N. Papadopoulos, Mary Achim, Karen E. Hoffman, Thomas J. Pugh, Seungtaek Choi, Patricia Troncoso, Christopher J. Logothetis and Jeri Kim

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer
J. Kellogg Parsons, John P. Pierce, James Mohler, Electra Paskett, Sin‐Ho Jung, Michael J. Morris, Eric Small, Olwen Hahn, Peter Humphrey, John Taylor and James Marshall

Baseline and longitudinal plasma caveolin‐1 level as a biomarker in active surveillance for early‐stage prostate cancer
Spyridon P. Basourakos, John W. Davis, Brian F. Chapin, John F. Ward, Curtis A. Pettaway, Louis L. Pisters, Neema Navai, Mary F. Achim, Xuemei Wang, Hsiang‐Chun Chen, Seungtaek Choi, Deborah Kuban, Patricia Troncoso, Sam Hanash, Timothy C. Thompson and Jeri Kim

Prostate cancer family history and eligibility for active surveillance: a systematic review of the literature
Jaya M. Telang, Brian R. Lane, Michael L. Cher, David C. Miller and James M. Dupree

Feasibility for active surveillance in biopsy Gleason 3 + 4 prostate cancer: an Australian radical prostatectomy cohort
Lih‐Ming Wong, Vincent Tang, Justin Peters, Anthony Costello and Niall Corcoran

Risk‐stratification based on magnetic resonance imaging and prostate‐specific antigen density may reduce unnecessary follow‐up biopsy procedures in men on active surveillance for low‐risk prostate cancer
Arnout R. Alberts, Monique J. Roobol, Frank‐Jan H. Drost, Geert J. Leenders, Leonard P. Bokhorst, Chris H. Bangma and Ivo G. Schoots

Gleason pattern 4: active surveillance no more
Niranjan J. Sathianathen, Declan G. Murphy, Roderick C. N. Bergh and Nathan Lawrentschuk

Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study
Leonard P. Bokhorst, Inari Lepistö, Yoshiyuki Kakehi, Chris H. Bangma, Tom Pickles, Riccardo Valdagni, Arnout R. Alberts, Axel Semjonow, Petra Strölin, Manuel F. Montesino, Viktor Berge, Monique J. Roobol and Antti Rannikko

 

Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low‐risk prostate cancer receiving 5α‐reductase inhibitors
Vincent Fradet  Paul Toren Molière Nguile‐Makao Michele Lodde Jérome Lévesque Caroline Léger André Caron Alain Bergeron Tal Ben‐Zvi Louis Lacombe Frédéric Pouliot Rabi Tiguert Thierry Dujardin Yves Fradet

 

Variation in serum prostate‐specific antigen levels in men with prostate cancer managed with active surveillance
Behfar Ehdaie  Bing Ying Poon Daniel D. Sjoberg Pedro Recabal Vincent Laudone Karim Touijer James Eastham Peter T. Scardino



Best of Australia and New Zealand 2018

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer
Pim J. van Leeuwen, Louise Emmett, Bao Ho, Warick Delprado, Francis Ting, Quoc Nguyen and Phillip D. Stricker

ProCare Trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer
Jon D. Emery, Michael Jefford, Madeleine King, Dickon Hayne, Andrew Martin, Juanita Doorey, Amelia Hyatt, Emily Habgood, Tee Lim, Cynthia Hawks, Marie Pirotta, Lyndal Trevena and Penelope Schofield

Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria
Brian Ngo, Nathan Papa, Marlon Perera, Damien Bolton and Shomik Sengupta

Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review
Brian Ngo, Marlon Perera, Nathan Papa, Damien Bolton and Shomik Sengupta

A qualitative perspectival review of the Australian and New Zealand Urology Education and Training program
Prem Rashid

Parents’ perceptions of counselling following prenatal diagnosis of congenital anomalies of the kidney and urinary tract: a qualitative study
Sarah Marokakis, Nadine A. Kasparian and Sean E. Kennedy

Mini PCNL for renal calculi: does size matter?
Derek B. Hennessey, Ned K. Kinnear, Andrew Troy, David Angus, Damien M. Bolton and David R. Webb

A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy
Pim J. van Leeuwen, Andrew Hayen, James E. Thompson, Daniel Moses, Ron Shnier, Maret Böhm, Magdaline Abuodha, Anne-Maree Haynes, Francis Ting, Jelle Barentsz, Monique Roobol, Justin Vass, Krishan Rasiah, Warick Delprado and Phillip D. Stricker

Fake news and clickbait – natural enemies of evidence-based medicine
Damien M. Bolton and John Yaxley

TANGO - a screening tool to identify comorbidities on the causal pathway of nocturia
Wendy F. Bower, Georgie E. Rose, Claire F. Ervin, Jeremy Goldin, David M. Whishaw and Fary Khan



Celebrating the legacy of John Wickham

Blog: Light Years Ahead – John Wickham (1927 – 2017) by Prokar Dasgupta

John Wickham’s seminal papers in BJU International

Comparison of prostatic volume and dimensions by transrectal and transurethral ultrasonography
Nathan MS, Mei Q, Seenivasagam K, Davies B, Wickham JE, Miller RA.

Rate of development of ureteric obstruction in idiopathic retroperitoneal fibrosis (peri-aortitis).
Baker LR, Croxson R, Khader N, Reznek RH, al Rukhaimi M, Wickham JE

The changing practice of percutaneous stone surgery. Review of 1000 cases 1981-1988
Jones DJ, Russell GL, Kellett MJ, Wickham JE

1500 cases of renal and ureteric calculi treated in an integrated stone centre.
Das G, Dick J, Bailey MJ, Fletcher MS, Birch B, Coptcoat MJ, Webb DR, Kellett MJ, Whitfield HN, Wickham JE

Lasertripsy for ureteric stones in 120 cases: lessons learned.
Coptcoat MJ, Ison KT, Watson G, Wickham JE

Percutaneous ring nephrostomy.
Miller RA, Ramsay JW, Whitfield HN, Kellet MJ, Wickham JE.

Combination of percutaneous surgery and extracorporeal shockwave lithotripsy for the treatment of large renal calculi.
Dickinson IK, Fletcher MS, Bailey MJ, Coptcoat MJ, McNicholas TA, Kellett MJ, Whitfield HN, Wickham JE

The effects of double J stenting on unobstructed ureters. An experimental and clinical study
Ramsay JW, Payne SR, Gosling PT, Whitfield HN, Wickham JE, Levison DA.

Frusemide intravenous urography in the diagnosis of pelviureteric junction obstruction
Whitfield HN, Britton KE, Hendry WF, Wickham JE.

Laser fragmentation of renal calculi
Watson GM, Wickham JE, Mills TN, Bown SG, Swain P, Salmon PR

Renal accumulation of ammonia: the cause of post-ischaemic functional loss and the "blue line"
Fitzpatrick JM, Monson JR, Gunter PA, Watkinson LE, Wickham JE

Conservation surgery of renal carcinoma: the EIRSS experience
Marberger M, Pugh RC, Auvert J, Bertermann H, Costantini A, Gammelgaard PA, Petterson S, Wickham JE

Percutaneous nephrolithotomy
Wickham JE, Kellett MJ

Hypothermic nephrolithotomy in solitary kidneys
Perry NM, Wickham JE, Whitfield HN

Improved techniques in radionuclide imaging of prostatic lymph nodes
Gardiner RA, Fitzpatrick JM, Constable AR, Cranage RW, O'Donoghue EP, Wickham JE

A computer-based record and organisation system for a department of urology
Wickham JE, Charlton CA, Richards B, Hendry WF, Ward JP, O'Donoghue EP, Hamshere RG, Franklin DA

Continuous perfusion of human cadaveric kidneys for transplantation
Stephenson TP, Hendry WF, Ward JP, Wickham JE

Regional renal hypothermia
Wickham JE, Hanley HG, Joekes AM.